Related Experiment Video
Updated: Jun 4, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Glucose concentration in the dialysate does not contribute to lipid profiles in patients undergoing CAPD
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China. drzhengli2009@126.com
Insights
Patients with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD) exhibit dyslipidemia. Dialysate glucose concentrations did not correlate with altered lipid profiles in CAPD patients.
Area of Science:
- Nephrology
- Clinical Biochemistry
- Metabolic Disorders
Background:
- End-stage renal disease (ESRD) frequently leads to dyslipidemia.
- Dialysis modalities, including hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), may influence lipid profiles.
- Understanding dyslipidemia in ESRD patients is crucial for managing cardiovascular risk.
Purpose of the Study:
- To investigate and compare lipid profiles across different ESRD treatments: nondialytic treatment (NT), HD, and CAPD.
- To analyze the association between dyslipidemia in CAPD patients and the glucose concentration in dialysate.
- To identify specific lipid abnormalities in ESRD patients undergoing various treatments.
Main Methods:
- Lipid profiles (cholesterol, triglycerides, HDL, LDL, Apo-A1, Apo-B, Apo-E) were measured in NT (n=64), HD (n=62), and CAPD (n=180) patients.
- Data from NT patients were collected post-hospitalization; HD and CAPD samples were taken after 3 months of treatment.
- Pearson correlation was used to assess the relationship between CAPD patient lipid profiles and dialysate glucose levels.
Main Results:
- Dyslipidemia was prevalent across all groups: 76.56% in NT, 66.13% in HD, and 72.22% in CAPD patients.
- CAPD patients showed significantly altered levels of cholesterol, triglycerides, HDL, Apo-A1, and Apo-E compared to NT patients (p < 0.05).
- No significant correlation was found between dialysate glucose concentrations and lipid profiles in CAPD patients.
Conclusions:
- Patients undergoing CAPD exhibit significant dyslipidemia.
- The concentration of glucose in the dialysate does not appear to influence lipid profiles in CAPD patients.
- Dyslipidemia is a common comorbidity in ESRD patients, irrespective of dialysis modality, necessitating further investigation and management strategies.
Abstract:
The aim of this study was to investigate lipid profiles in patients with end-stage renal disease receiving hemodialysis (HD), continuous ambulatory peritoneal dialysis (CAPD), or no dialysis (nondialytic treatment group, NT), and to analyze the association between dyslipidemia in CAPD patients with glucose-containing dialysate dosages. Lipid profiles were determined in 64 NT patients, 62 HD patients, and 180 CAPD patients at a single time point. NT patients' samples were collected following hospitalization due to renal failure. HD and CAPD patients' samples were collected after 3 months of dialysis. The association between lipid profiles of 180 CAPD patients and glucose-containing dialysate was analyzed using Pearson methods; 76.56% of NT patients, 66.13% of HD patients, and 72.22% of CAPD patients had dyslipidemia. Compared with NT patients, CAPD patients had significantly altered levels of cholesterol, triglycerides, high-density lipoprotein, apolipoproein (Apo)-A1, and Apo-E (p < 0.05), but unchanged levels of low-density lipoprotein or Apo-B. There was no correlation between the three different concentrations of glucose in the dialysate with the lipid profile of CAPD patients. We concluded that patients on CAPD exhibit dyslipidemia, and that different concentrations of glucose in the dialysate do not affect lipid profiles in these patients.
More Related Videos
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
14:42Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
Published on: September 23, 2021
Related Concept Videos
Dialysis
Peritoneal Dialysis I: Introduction and Procedure
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Absorption Into the Small Intestine
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...